Phenotypic changes of Trichinella spiralis treated by Commiphora molmol,Lepidium sativum, and Albendazole: in vitro study Cover

.blurhash-client-img { display: none !important; }

Phenotypic changes of Trichinella spiralis treated by Commiphora molmol,Lepidium sativum, and Albendazole: in vitro study

Volume 59 (2022): Issue 1 (March 2022)

By: G. L. Abuelenain, Z. H. Fahmy, A. M. Elshennawy, E. H. A. Selim, M. Elhakeem, K. M. A. Hassanein and S. M. Awad

Open Access

|May 2022

Authors

G. L. Abuelenain

gehan.abuelenain@fchs.ac.ae

Parasitology Lab, Department of Immunology and Drug Evaluation, Giza, Egypt

Z. H. Fahmy

Parasitology Lab, Department of Immunology and Drug Evaluation, Giza, Egypt

A. M. Elshennawy

Parasitology Lab, Department of Immunology and Drug Evaluation, Giza, Egypt

E. H. A. Selim

Parasitology Lab, Department of Immunology and Drug Evaluation, Giza, Egypt

M. Elhakeem

Water Resources and Environmental Engineering, ADU, UAE

University of Tennessee, Knoxville, USA

K. M. A. Hassanein

Electron Microscope Department, Assuit University, Asyut, Egypt

S. M. Awad

Fatima College of Health Sciences, ADU, UAE

DOI: https://doi.org/10.2478/helm-2022-0005 | Journal eISSN: 1336-9083 | Journal ISSN: 0440-6605

Journal RSS Feed

Language: English

Page range: 37 - 45

Submitted on: Oct 1, 2021

Accepted on: Jan 4, 2022

Published on: May 4, 2022

Published by: Slovak Academy of Sciences, Institute of Parasitology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Drug discovery,

Complimentary drug,

auxiliary drug,

Related subjects:

Life sciences, other,

Clinical medicine,

Microbiology, virology and infection epidemiology

© 2022 G. L. Abuelenain, Z. H. Fahmy, A. M. Elshennawy, E. H. A. Selim, M. Elhakeem, K. M. A. Hassanein, S. M. Awad, published by Slovak Academy of Sciences, Institute of Parasitology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 59 (2022): Issue 1 (March 2022)Next article